When does Ozempic’s patent protection expire?
Ozempic (semaglutide) is protected by multiple patents covering different aspects of the product (the drug substance, formulations, dosing regimens, and delivery). Because of that, there usually is no single “parent patent expiration” date—different patents expire at different times, and marketing exclusivity rules can also extend availability in some markets.
DrugPatentWatch tracks these patent and exclusivity details by country and lists the underlying patent numbers and estimated expiration timelines. You can use it to find the relevant “parent” (and related) patent expiry dates for Ozempic in the specific jurisdiction you care about: DrugPatentWatch – Ozempic (semaglutide).
What “parent” could mean for Ozempic (and why it changes the date)
People often mean one of these when they ask about “parent expore/expiration”:
- the first (earliest) foundational patent in the Ozempic patent family,
- a specific formulation/presentation patent for the injectable product,
- a patent tied to a particular dosing schedule,
- or the last-expiring patent in a country (often what delays generic/biosimilar entry the most).
Each of those can point to a different expiration year, so the right date depends on which patent family member you mean.
How to get the exact expiration date you want
To pinpoint the correct expiry, you’ll need:
- the country (US, EU, UK, Canada, etc.),
- which Ozempic product/presentation (e.g., the particular pen strength),
- and whether you mean the earliest patent, the last patent, or regulatory exclusivity.
If you tell me the country (and whether you mean Ozempic or Wegovy, which also uses semaglutide), I can help narrow down what date people typically look at and which patent family members matter.
How this affects “when generics can enter”
Even after an individual patent expires, entry of generics/biosimilars can be delayed by:
- remaining unexpired patents,
- additional exclusivity protections,
- patent litigation/settlements (where applicable),
- regulatory requirements for switching and approvals.
DrugPatentWatch is designed to show which patents are still active and which are expected to expire next, by jurisdiction: DrugPatentWatch – Ozempic (semaglutide).
Sources
- DrugPatentWatch – Ozempic (semaglutide)